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Abstract. After the intraportal injection of EGF, the
EGF receptor (EGFR) is rapidly internalized into he-
patic endosomes where it remains largely receptor
bound (Lai et al., 1989. J. Cell Biol. 109:2751-2760) .
In the present study, we evaluated the phosphotyrosine
content of EGFRs at the cell surface and in endosomes
in order to assess the consequences of internalization.
Quantitative estimates of specific radioactivity of the
EGFR in these two compartments revealed that tyro-
sine phosphorylation of the EGFR was observed at the
cell surface within 30 s of ligand administration. How-
ever, the EGFR was also highly phosphorylated in en-
dosomes reaching levels of tyrosine phosphorylation
significantly higher than those of the cell surface re-
ceptor at 5 and 15 min after EGF injection. A 55-kD
WE and others have used subcellular fractionation
and associated approaches in an attempt to deline-
ate the components of rat liver involved in insulin,
prolactin, and EGF receptor (EGFR)l internalization in
vivo (Bergeron et al., 1985 ; Dunn and Hubbard, 1986 ; Khan
et al ., 1986, 1989 ; Lai et al., 1989a,b) . Past studies have re-
vealed that after internalization into endosomes (5-15 min)
the ligand, EGF, remained largely associated with the pe-
riphery of endosomes . This was revealed by EM radioautog-
raphy of the distribution of silver grains from [1151]EGF
within endosomes in situ of the placental syncytiotropho-
blast (Lai et al., 1986) and for the distribution of [12SI]EGF
within isolated rat liver endosomes (Lai et al., 1989b) . Di-
rect visualization of internalized EGF by protein-A gold EM
immunolabeling of endosomes in A431 cells has been dem-
onstrated by Carpentieret al. (1987) and biochemical studies
that evaluated the degree of ligand receptor association after
polyethylene glycol precipitation of the complexes from
solubilized endosomes revealed that the majority of internal-
ized EGF within such components ofliverparenchymal cells
was receptor bound (Lai et al., 1989b). These studies as well
as the observations that demonstrated enhanced autophos-
phorylation activity of the EGFR in isolated rat liver endo-
somes (Kay et al ., 1986; Lai et al., 1989b) predicted that the
1. Abbreviations used in this paper: EGFR, EGF receptor; GE, Golgi en-
dosomal; PM, plasma membrane.
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tyrosine phosphorylated polypeptide (pyp55) was ob-
served in association with the EGFR at the cell sur-
face within 30 s of EGF injection. The protein was
also found in association with the EGFR in endosomes
as evidenced by coprecipitation studies using a mAb to
the EGFR as well as by coelution with the EGR in gel
permeation chromatography. Limited proteolysis of
isolated endosomes indicated that the tyrosine phos-
phorylated domains of the EGFR and associated pyp55
were cytosolically oriented while internalized EGF
was intraluminal. The identification of pyp55 in asso-
ciation with EGFR in both hepatic plasma membranes
and endosomes may be relevant to EGFR function and/
or trafficking of the EGFR.
phosphotyrosine content of the EGFR subsequent to inter-
nalization must remain elevated at least during transit of the
receptor through the endosomal compartment(s). We have
attempted to test this prediction by quantitation of the in vivo
state of tyrosine phosphorylation of the receptor at the cell
surface and after internalization into endosomes. Larkin et
al. (1986) demonstrated the feasibility of labeling hepatic re-
ceptors such as the polymeric IgA receptor after whole ani-
mal injection of 32pi. We have consequently followed this
approach to label the EGFR in vivo, and in conjunction with
antibodies specific to phosphotyrosine have observed that
the EGFR is indeed highly tyrosine phosphorylated after in-
ternalization into endosomes after initial phosphorylation at
thecell surface. Furthermore, we have observed a novel tyro-
sine phosphorylated protein of 55 kD (pyp55) in association
with the EGFR both at the cell surface and after receptor in-
ternalization into endosomes. The orientation of the EGFR
and pyp55 in isolated endosomes is such that their tyrosine
phosphorylated domains are cytosolically oriented.
Materials and Methods
Materials
EGF was purchased from Collaborative Research (Waltham, MA) and insu-
lin was a gift from the Connaught Laboratories (Toronto, Ontario). [-y-"P]-
ATP (3,000 Ci/mmol), [32plorthophosphate (900 mCi/mmol), and Na[ill]
321were purchased from Dupont Canada (Mississauga, Ontario). Thin layer
plates (E. Merck; 0.1 mm cellulose, 20 x 20 cm) were obtained from BDH
(Montreal, Quebec). All other chemicals were from Sigma Chemical Co.
(St. Louis, MO), Anachemia Canada Inc. (Lachine, Quebec), and Boeh-
ringer Mannheim (Montreal, Quebec). Sprague-Dawley rats were obtained
from Charles River Ltd. (St. Constant, Quebec). For all experiments, rats
were injected via the hepaticportal veinand sacrificed at various times after
the injection of saturating doses (Lai etal., 19ß9a) ofEGF (10pg/100g bw).
Antibodies
The hybridoma secreting anti-EGFR mAb was a gift from Dr. C. E. Chan-
dler and was subcloned (IgG-151, BH-6) by Drs. W. A. Dunn and A. L.
Hubbard (The Johns Hopkins University, Baltimore, MD). The antibodies
were isolated from hybridomas as described by Lai et al. (19ß9b). Phos-
photyrosine was conjugated to keyhole limpet hemocyanin by using 1-ethyl-
3-(3-dimethyl amino)-1-naphthalene-sulfonic acid and was used to raise an-
tibodies against phosphotyrosine in rabbits. Antibodies were obtained by
phosphotyrosine conjugated to Affigel 15 (Bio Rad, Mississauga, Ontario)
column chromatography. The specificity of the antibodies was evaluated by
immunoprecipitation and immunoblotting of the tyrosine phosphorylated
EGFR. Thus, both immunoprecipitation and Western blotting were in-
hibitedbyphosphotyrosine but notphosphoserine orphosphothreonine (not
shown) . Site-specific antibodies against peptide PI (residues 1,164-1,176
KGSTRENAEYLRV) and against peptide P3 (DDTFLPVPEYINQS,
residues 1,059-1,072) ofthe EGFR (Downward et al., 1984) were synthe-
sized by Dr. N. Ling (The SalkInstitute, San Diego, CA). The peptides were
coupled to keyhold limpet hemocyanin and polyclonal antibodies were
raised after injection into rabbits (Lai et al., 19ß9a).
In Vivo Labeling ofAnimals, Preparation ofPlasma
Membrane and Endosome Fractions, Determination
ofReceptor Content
Male Sprague-Dawley rats (120-130 g) received 5 MCi of [32P]or-
thophosphate via the portal vein. EGF also was injected via the portal vein.
The livers were removed at 1 h after the injection of [32P] orthophosphate
and homogenized immediately in ice-cold homogenization buffer (0.25 M
sucrose, 1 MM MgC12, 5 mM iodoacetamide, 4 mM NaF, 100 uM
Na3VO4, 10 mM 0-glycerophosphate, 5 mM p-nitropherrylphosphate, 5 mM
Na2MoO4, 0.5 mM ATP, 2 mM benzamidine, 500 KIU Aprotinin per ml,
0.5 mM PMSF, 20 mM Tris-HCI, pH 7.5) with the Dounce homogenizer
(type B) to give a 15% (wt/vol) homogenate. The plasma membrane (PM)
fraction was isolated from the homogenate basically as described by Kay
et al. (1986) exceptforthe addition of0.5 mM ATP, 10 mM ß-glycerophos-
phate, 5 mMp-nitrophenylphosphate (final concentrations) to the homoge-
nate and all centrifugation buffers. The PM fraction was subsequently
purified from the combined 2ß0-g and 1,500-g pellets as described by Kay
et al. (1986) and Lai et al. (19ß9a). The resultant supernatant was used to
purify the endosome (GE) fractions. The supernatantwas adjusted to 1.1 M
sucrose by adding 2.3 M sucrose in homogenization buffer (vide supra). A
discontinuous gradient of0.4 and 0.95 M sucrose containing the same buffer
constituents as above was overlaid above the load zone (1:1 vol) . Subsequent
centrifugation (85,000 g, for 150 min, Beckman SW28 rotor without the
brake) yielded a GE fraction at the interface ofthe 0.4 and 0.95 M sucrose
layers. The fraction was identical to that described by Kay et al. (1986), Lai
et al. (1989a,b) and Doherty et al. (1990) as evaluated by EM, SDS-PAGE,
ligand binding ([u5I]EGF), and the enzyme activities of 5' nucleotidase
and galactosyl transferase (data not shown) .
At 0, 0.5, 5, and 15 min after the portal vein injection of EGF (10 pg/
100 g bw), PM and GE fractions were prepared and EGFR content was
evaluated. However, the high concentration ofinternalized EGF in GE frac-
tions preventedthe determination ofEGFR content from inhibition dose re-
sponse binding data (Lai et al., 19ß9a). Consequently immunoblotting,
using site-specific antibody directed against peptide PI of the EGFR (vide
supra, followed by densitometry as described by Lai et al. [19ß9a] [see
Fig. 3 ofthis reference]) was used to determine a linear relationshipbetween
densitometry and receptor content over a range of5-100,ug of subcellular
fraction protein. The densitometric units derived from immunoblotting
were normalized for the EGFR content of PM and GE fractions isolated
from the livers of control (noninjected) rats as determined from [1251]EGF
inhibition dose response binding data.
Immunoprecipitation
PM or GE fractions were pelleted by centrifugation at 10,000 g for 20 min
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(PM) or 100,000 g for 45 min (GE) after a fourfold dilution with the
homogenization buffer. To precipitate the EGFR, membranes were solubi-
lized with 5 % Triton X-100, 2.5% sodium deoxycholate, 10% glycerol, 0.15
M NaCl, 5 mM iodoacetamide, 5 mM p-nitrophenylphosphate, 2 mM
Na3VO4, 20 mM NaF, 10 mM ß-glycerophosphate, 50 mM sodium phos-
phate buffer, pH 7.5, at 4°C for 30 min and diluted 10-fold with 0.1% BSA,
0.15 M NaCl, 5 mM p-nitrophenylphosphate, 100 mM sodium phosphate
buffer, pH 6, then centrifuged at 50,000 g for 30 min. mAb against the
EGFR (100 IAg protein, IgG) was added to the supernatant (from 1 mg pro-
tein of PM or GE) and incubated for 15 min at 0°C followed by another
incubation with Pansorbin for 1 h at 4°C. The immune complex was washed
five times (5 min, 10,000 g) with 0.1% BSA, 0.1% Triton X-100, 0.15 M
NaCl, 2 mM Na3VO4, 10 mM ß-glycerophosphate, 100 mM sodium phos-
phate buffer, pH 7.5. The immune complex was resuspended in 1.5 % SDS,
5% glycerol, 50 mM Tris-HCI, pH 6.8, 5% 0-mercaptoethanol, and in-
cubated for 15 min at 65°C. SDS-PAGE was carried outwith a gradient gel
of 5-15% acrylamide. Resolved phosphoproteins on thegel were visualized
by radioautography using Kodak X-GMAT X-ray films with enhancing
screens. Intensity ofthe bands was quantifiedby densitometry with a Zeineh
soft laser scanning densitometer interphased with an IBM PC using a
GS350 Data System (Hoffer Scientific Instruments).
Gel Permeation Chromatography of
Endosomal Proteins
The GE fractionwassolubilizedas described for immunoprecipitation (vide
supra). The solubilized endosomes were filtered through a 0.22-pm filter
and immediately applied onto a TSK 3000 SW column equilibrated with
0.15 M NaCl, 0.2% Tween 20, 10% glycerol, 0.1 mM sodium vanadate, 10
mM Tris-HCI, pH 7.5. The eluant (0.2 ml/min/tube) was fractionated by
reversed phase HPLC and 1 ml of 80% ethanol/20% n-hexanes was added
immediately into each fraction.
Peptide Mapping
Peptide mapping of [1251]EGFR and [1251]pyp55 was effected as follows:
GE fractions isolated at 15 min after injection ofEGF were solubilized with
1% Triton X-100, 0.5% deoxycholate, 10 mM Tris-HCI, pH 7.5, 10%
glycerol for 15 min on ice and were incubated with -10 U ofalkaline phos-
phatase (purified from Bovine intestinal mucosa; Sigma Chemical Co.,
Type VII-N) for 10 min at room temperature. The sample was iodinated
with 1 mCi of Na[1211] by using Iodo Beads (Pierce) . Free iodine was re-
moved by Sephadex G-25 (10 x 50 mm) column chromatography
equilibrated with 0.1% BSA, 0.1% Triton X-100, 10% glycerol, 0.15 M
NaCl, 10 mM Tris-HCI, pH 7.5. The void fraction was centrifuged at
100,000 g for 30 min after preincubation with Pansorbin for 15 min at room
temperature (in order to remove nonspecific binding to Pansorbin). The su-
pernatant was then incubated with EGFR antibody for 15 min at room tem-
perature followed by another incubation with Pansorbin for 10 min at room
temperature. The immunecomplex was recovered by centrifugation (10,000g
for5 min) and washed as described above. The immunecomplex was treated
under nonreducing conditions in order to minimize contamination with IgG
heavy chain with 1.5% SDS, 5% glycerol, 50 mM Tris-HCI, pH 6.8, at
65°C for 10 min and resolved by SDS-PAGE. The bands corresponding to
the EGFR and pyp55 were excised and tryptic peptides were obtained as
follows: gel pieces were washed with 85 % acetone, 5% triethylamine, 5 %
acetic acid, 5 % water followed by 50mM N-ethylmorpholine, then homog-
enized in 1 ml of 50 mM N-ethylmorpholine as described by Tomqvist et
al. (1987). The gel suspensionswere incubated with 50 ug of TPCK trypsin
for 3 h at 37°C with rotation followed by incubation with another 50 pg/ml
ofTPCK trypsin for 10-12 h at 37°C as described by lbrngvist et al. (1987).
[1251] peptides were then resolved on cellulose plates at 500 V for 30 min
in 30% formic acid for the 1st dimension, and the second dimension was
chromatographed in n-butanol, acetic acid, pyridine, H2O (6:12:40:48) as
described in Fig. 4. The plates were exposedto X-ray film for 1 wk (EGFR)
or 30 d (pyp55) after staining with ninhydrin.
Limited Protease Digestion ofthe EGFR in Endosomes
GE fractions were isolated 15 min after the injection of 10 jug/100 g bw of
EGF as described (Lai et al., 1989a,b) in the presence ofthe phosphatase
inhibitors, 2 mM NaF, 100 AM Na3VO4, and 5 mM p-nitrophenylphos-
phate. Fractions (25 wg membrane protein) were incubated with increasing
concentrations of trypsin at 0°C for 30 min in the presence or absence of
Triton X-100 following which aprotinin at 2.5 times the respective concen-
tration of trypsin was added.
322Results
Subcellular fractionation was employed to separate hepatic
PM from endosome fractions ofliver homogenates prepared
at various times after the intraportal injection of saturating
doses of EGF (10 Ag/100 g bw; Lai et al., 1989a) . This was
followed by an assessment of EGF receptor concentration in
the two fractions by quantitative immunoblotting with site-
specific antibody to the EGFR as well as the level of tyrosine
phosphorylation of the EGFR by in vivo labeling with "Pi.
Evaluation ofReceptor Concentration in PM and
Endosome Fractions
Rapid loss of receptor from the PM and rapid concentrative
internalization into endosomes was observed (Table I a as
described previously [Lai et al., 1989a]) with a 4.3-fold de-
crease in the concentration of EGFR in PM fractions and an
11-fold increase in receptor concentration in the endosome
fraction during 15 min after the injection of EGF.
Phosphotyrosine Content ofthe EGFR
We next assessed the in vivo phosphorylation of the EGFR
after sequential injections of "Pi and EGF after which
specific immunoprecipitation of the EGFR was done on
solubilized PM and endosome fractions isolated from the
same liver homogenates (Table I b). After the injection of
5 mCi of "Pi, the specific radioactivity of hepatic ATP was
evaluated by the method of England and Walsh (1976) and
foundto be constant at 0.74 Ci/mol for 30-75 min after injec-
tion. Consequently, 30 min after the injection of "Pi, EGF
was injected and both PM and GE fractions were isolated
from liverhomogenates of rats killed at 0, 30 s, 5 and 15 min
after injection. The EGFR was immunoprecipitated with
mAb IgG 151-BH6 (Lai et al., 19896) and subjected to SDS-
PAGE. Maximum labeling of the receptor (170 kD) in the
PM was observed at 30 s after the injection of EGF after
which labeling diminished (Fig. 1 A). However, in endo-
somes, increased labeling was found up to 15 min after EGF
injection . Alkali treatment of gels (Fig. 1 B) demonstrated
labeling on phosphotyrosineresidues for the immunoprecip-
itated EGFR in PM as well as in endosomes. Densitometry
of the X-ray films of immunoprecipitated EGFR after SDS-
PAGE and alkali treatment showed that alkali-resistant 32p-
TableI. Ligand-mediated Changes in the Contentand Specific Radioactivity ofthe EGFR in PMand GE Fractions
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label in EGFRs remained nearly constant in PM fractions
(when expressed per mg cell fraction protein), but increased
markedly in endosomes (Table I b). This approach enabled
an estimation ofthe specific radioactivity of the receptor (Ta-
ble I c) . Receptor-specific activity increased significantly in
PM between 0 and 30 s after EGF injection but changed little
thereafter. However, the specific radioactivity of the EGFR
in the GE fraction did not change for the first 30 s after ligand
administration despite a twofold increase in receptor concen-
tration (see Table 1, a and c). Subsequently, receptor specific
activity increased eightfold between 30 s and 5 min after
ligand injection and remained constant to 15 min . Of note
the specific radioactivity values of the EGFR in endosomes
were 2 .9- and 2.3-fold higher respectively than the corre-
sponding values for the receptor in PM at 5 and 15 min after
injection.
Qualitatively similar findings were observed when experi-
ments were evaluated by immunoblotting with antiphospho-
tyrosine antibodies. Immunoblotting of total cell fraction
protein transferred onto nitrocellulose sheets revealed a ma-
jor immunoreactive polypeptide at 170 kD whose temporal
immunoreactivity in PM and endosomes was similar to that
of the 32P-labeled immunoprecipitated EGFR (see Fig. 1).
This was confirmed by immunoprecipitation studies which
demonstrated that the major immunoreactive band at 170 kD
was indeed the EGFR (Fig. 2 B).
Identification ofan EGFR-associatedPolypeptide
of55 kD
In the above experiments, a polypeptide of 55 kD was also
immunoprecipitated by the EGFR antibody (Figs. 1 and 2) .
Because 32P labeling of this protein persisted after alkali
treatment ofthe gels and because it was detected by immuno-
blotting with phosphotyrosine antibody it is referred to as
pyp55. Indeed, in both PM and endosome fractions the
pyp55 band was the major antiphosphotyrosine reactive
band besides that ofthe EGFR at 170 kD (Fig. 2). Other im-
munoreactive bands were observed at 47 and 64 kD (Fig. 2
A) . However, these proteins did not coimmunoprecipitate
consistently with the EGFR (see Figs. 1 and 2 B).
The immunoprecipitation studies (Figs. 1 and 2) suggested
an association of pyp55 with the EGFR which was evaluated
by an alternative approach (Fig. 3). Endosomal fractions,
* Time (min) after the injection of EGF.
$ Receptor content (mean [n = 41 f SD) was calculated from quantitative immunoblotting as described in Materials and Methods.
§ 32P-labeled EGFR was evaluated by densitometry of radioautographs of immunoprecipitated EGFR subjected by SDS-PAGE and alkali-treatment (mean
[n = 31 * SD).
N Specific radioactivity, calculated as the ratio of column b/column a.
1 Significantly different from the specific radioactivity of the EGFR at 5 min in PM (P < 0.05, Student's t test).
** Significantly different from value in PM at 15 min (P < 0.01).
a b
Receptor content
No. x 10-"/mg protein*
31P phosphotyrosine
units/mg protein§ Specific
c
radioactivityll
Time*
min
PM GE PM GE PM GE
0 1 .59 t 0.23 0.30 t 0.1 3.2 t 1 .1 1 .0 0.6 2.0 0.8 3.3 t 2.5
0.5 1.02 t 0.36 0.65 t 0.16 10.0 f 4.2 3.0 f 1.0 10.2 t 7.1 4.6 f 2 .0
5 0.52 t 0.13 2.13 t 0.39 6.6 t 2.1 78.4t16.5 12 .6t4.9 36.8t10.71
15 0.37 t 0.07 3.28 f 0.26 6.2 t 0.8 123.3t 10.3 16 .7t4.2 37.6t4.4**Figure 1. Immunoprecipitation of in vivo 32p-labeled EGFR . (A and B) EGF was injected at 0, 30 s and 5 min (experiment I) or at 5 and
15 min (experiment II) into the portal vein of rats that had previously received 5 MCi of 32P orthophosphate . PM and GE fractions were
isolated and subjected to immunoprecipitation (PM, 700 wg ; GE, 350 Wg protein) followed by SDS-PAGE . All animals were killed at
60 min after injection of 3zp orthophosphate. The gels were exposed to X-ray film for 3 d (A, lanes 1-10), then treated with alkali and
re-exposed for 10 d (B) . The position of the EGFR is indicated by the arrow. As well, in B, the mobilities of the phosphoprotein designated
pyp55 and that of a band of molecular mass 47 kD (asterisk) are noted .
isolated 15 min after the injection of EGF, were solubilized
and the proteins separated byHPLC gel permeation chroma-
tography. Eluted fractions were electrophoresed, transferred
to nitrocellulose sheets, and probed with the antiphosphoty-
rosine antibody as well as site-specific antibodies to the
EGFR . Fractions eluting at a molecular weight of -440,000
were reactive with both sets of antibodies . Two major pro-
teins were immunoreactive with antiphosphotyrosine anti-
bodies ; one at a molecular mass of 170 kD corresponded to
theEGFR as evidenced by immunoblotting with site specific
antibodies . The other protein which was immunoreactive
with antiphosphotyrosine antibody had a molecular mass
identical to pyp55. Whereas the EGFR was found between
fractions 8-15, pyp55was restricted to fractions 8-11 as well
as in monomeric form (-60,000 in molecular weight [not
shown]) . This was probably due to dissociation consequent
to dilution during chromatography. However, the majority of
theEGFR in endosomes was ofhigher order structure either
The Joumal of Cell Biology, Volume 116, 1992
in association with pyp55 (fractions 8-11) or with itself (frac-
tions 12-15, -340,000 in molecular weight) .
Ttvo-dimensional peptide analysis was carried out on the
EGFR and pyp55 after solubilization, radiolabeling with
Na['z5I], and immunoprecipitation with anti-EGFR anti-
body. No overlapping peptides were found (Fig. 4) indicating
that pyp55 was a distinct protein . Attempts to generate phos-
phopeptide maps were unsuccessful due to the low level of
32P incorporation and the lack of sensitivity of antiphospho-
tyrosine inununoblots after tryptic hydrolysis of the EGFR
and pyp55 (data not shown and vide infra, Fig . 5) .
Pyp55 did not bind to protein A (data not shown) and
therefore was not related to the heavy chain ofIgG (expected
molecular mass -55 kD) . Furthermore, pyp55 was not im-
munologically related to src asmAbMA327 (Lipsich et al .,
1983) to pp60grc (molecular mass 60 kD) did not immuno-
precipitate pyp55 from solubilized endosomes . Neither was
the protein related immunologically to the 55-kD tyrosine
324phosphorylated protein identified by Baribault et al . (1989)
since no reactivity was found on immunoblotting with anti-
bodies to this protein with either immunoprecipitates ofthe
EGFR ortotal endosomal proteins . Finally, phosphorylation
of pyp55 was dependent on EGF. The administration of
equivalent near saturating doses of insulin (15 /.g/100 g bw)
led to the endosomal accumulation of insulin receptors to
levels similar to those of the EGFR shown in Table I . How-
ever, no association of pyp55 with the insulin receptor was
found after immunoprecipitation nor was pyp55 phos-
phorylated after insulin administration as evaluated by West-
ern blotting with antiphosphotyrosine antibody.
Orientation andLocalization oftheIn Vivo Labeled
EGFR in Endosomes
Isolated endosomes were subjected to limited proteolysis to
evaluate the orientation of the EGFR and pyp55 in endo-
somes . Endosomes isolated 15 min after the injection of
EGF were treated with increasing concentrations of trypsin
at 0°C followed by immunoblotting with antiphosphotyro-
sine antibody. At the lowest dose of trypsin employed (0.4
jg/ml), immunoreactivity (with antiphosphotyrosine anti-
body) of the 170-kD EGFR as well as pyp55 was greatly di-
minished (Fig. 5 A ; quantified in Fig . 5 B) . Similar ob-
servations were found using site-specific antibody to the
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carboxyl-terminal tail of the EGFR (data not shown) . By
contrast, [t11I]EGF internalized into the same endosomes
was insensitive to this limited protease digestion in the ab-
sence but not the presence of detergent (Fig. 5 B) . Experi-
ments were attempted to immunolocalize directly antiphos-
photyrosine antibodies on isolated endosomes by the protein-
A gold technique as described by Dominguez et al . (1991) .
These were, however, without success presumably due to the
low signal (vide infra) .
Discussion
Our studies and those of others (Dunn and Hubbard, 1986 ;
Kay et al., 1986 ; Lai et al., 1989a) have demonstrated that
after EGF administration, the EGFR is rapidly internalized
into hepatic endosomes. We also found that the majority of
endosomal ligand (EGF) remains receptor bound even 15
min after the injection ofEGF (Lai et al ., 1989b) . The pres-
ent study was undertaken to evaluate the phosphotyrosine
content oftheEGFR in isolated endosomes with comparison
to what was observed at the cell surface .
The radioactivity in the 32P-phosphotyrosine-labeled
receptor was estimated by immunoprecipitating EGFR after
the intraportal injection of 32pi . Accurate determination of
EGFR concentration in the subcellular fractions was achieved
by quantitative immunoblotting (see also Lai et al., 1989a)
325Figure 2 . Immunoblot analysis ofEGFR and substrates by anti-phosphotyrosine antibody. Membrane fractions (50 ug) of PM (lanes 1-4)
and GE (lanes S-8) were isolated from rats sacrificed at 0, 0.5, 5, and 15 min after the injection ofEGE (A) The fractions were subjected
to SDS-PAGE and immunoblotted with antiphosphotyrosine antibody as described in Materials and Methods . (B) Endosomes (GE, 50
hg protein) were solubilized and after incubation with EGFR antibody, the immunoprecipitate was subjected to SDS-PAGE followed by
immunoblotting with antiphosphotyrosine antibody. At 15 min after the injection ofEGF additional bands at 47 and 64 kD are observed
in addition to the EGFR and pyp55. (C) GE and PM fractions (100 pg protein each) isolated at 0.5 and 15 min after the injection ofEGF
were incubated with 0.1 M sodium carbonate on ice for 30 min followed by centrifugation at 200,000 g for 30 min . The supernatants (S)
and pellets (P) were subjected to SDS-PAGE followed by immunoblotting with antiphosphotyrosine antibody. The positions corresponding
to the molecular masses of the EGFR and pyp55 are indicated .
using a site-specific antibody to the EGFR . 32P-phosphoty-
rosine content per unit receptor (i.e., specific radioactivity)
was then calculated from the densitometry of 32plabeled
immunoprecipitated EGFR divided by the receptor content .
The data clearly establish that ligand-dependent tyrosine
phosphorylation was initiated at the cell surface with a five-
fold increase in receptor specific activity observed in plasma
membranes within 30 sec after the administration ofEGF.
Endosomal receptor specific activity was significantly greater
than that of PM receptors at either 5 (P < 0.05) or 15 min
(P < 0.01) after injection . However, when calculated as the
fold increase in specific activity over that at zero time, re-
ceptor-specific activity in endosomes at 15 min was only
slightly greater (11.4-fold increase) than that calculated for
PM over the same time interval (8.4-fold increase) . (This dis-
crepancy was due to the high variation in the estimation of
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the low receptor concentration and low "P-labeling of the
EGFR in the GE fraction at zero time (Table I c)) . Though
consistent with the view that receptor phosphorylation was
enhanced in endosomes our data do not exclude the possibil-
ity that receptor phosphorylation occurred only in the PM
with highly phosphorylated receptors being preferentially
internalized . On the other hand, within the first 30 s after
EGF injection PM receptor specific activity increased five-
fold whereas endosomal receptor specific activity remained
similar to the low zero time level despite a twofold increase
in receptor concentration in endosomes. Here there would
appear to have been selective internalization of only poorly
phosphorylated cell surface EGFRs . Thus the hypothesis of
selective internalization appears to be a rather more compli-
cated explanation for our data .
The yield of the PM fraction was -14% based on the
326Figure 3 Coelution of pyp55 withEGFR in gel permeation chromatography. GE fractions (250,ug protein) isolated 15 min after the injec-
tion ofEGF (10 Ag/100 g bw) were solubilized as described in Materials and Methods . Eluted fractions were subjected to immunoblotting
with the anti-phosphotyrosine antibody (upper panel) or a mixture of site-specific antibodies against synthetic peptides corresponding to
residues 1,164-1,176 (aP1 Ab) and 1,059-1,072 (aP3 Ab) of theEGFR. Vo, void volume ; 440 K, elution position of ferritin ; 160 K, elution
position of -y-globulin . On the left is indicated the positions of the EGFR and pyp55.
receptor content ofthese fractions compared to thatofa total
particulate fraction (Lai et al ., 1989a) . The yield of endo-
somes was -32% (calculated from the receptor content in
endosomes at 15 min after injection of saturating levels of
EGF (Table I of the present study and Lai et al ., 1989a) as
compared to that of total particulate fractions of liver
homogenates (Lai et al ., 1989a) . EM of thePM fraction in-
dicated a representative cell fraction consisting of all do-
mains (sinusoidal, lateral, bile canalicular) of the hepatic
cell surface (Hubbard et al ., 1983 ; Lai et al ., 1989a) . This
was not the case for the endosomal fraction . The endosomal
components of the GE fraction consisted mainly of tubulo-
vesicular profiles with the vesicular components of ti 250-
300 nm in diameter containing intraluminal lipoprotein-like
particles (Lai et al ., 1989b ; Doherty et al ., 1990) . Themuch
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larger (and denser) multivesicular bodies were not found in
this fraction . Indeed, the studies employing limited proteol-
ysis of the GE fraction (Fig . 5) demonstrated that the tyro-
sine phosphorylated domain of the EGFR was cytosolically
oriented while internalized ['uI]EGF was intraluminal . Taken
together with past studies showing that at this dose of in-
jected ligand and at 15 min after injection, ['z1I]EGF was
largely receptor bound and localized to the bounding mem-
brane ofendosomes (Lai et al ., 1989b), we conclude that lit-
tle if any of internalized-EGF or tyrosine-phosphorylated
EGFR was sequestered within intraluminal vesicles of mul-
tivesicular bodies in the GE fraction . Other investigators
have clearly demonstrated internalized EGFR within such
structures (McKanna et al ., 1979 ; Hopkins, 1990; McCune
et al ., 1990) . It is, however, noteworthy that Carpentier et
327Figure 4. Two dimensional peptide maps ofEGFR (A) and pyp55 (B) . GE fractions were isolated at 15 min after the injection ofEGF.
The fractions were solubilized, dephosphorylated, and iodinated with Na[1251] as described in Materials and Methods. After immunopre-
cipitation with mAb to the EGFR, the radioiodinated EGFR and pyp55 were resolved by nonreducing SDS-PAGE, extracted from the
gel, and digested with TPCK trypsin . Resulting peptides were applied onto a cellulose plate equilibrated with 30% formic acid and the
[1251] labeled tryptic peptides were resolved electrophoretically in 30% formic acid, then by chromatography in n-butanol/acetic acid/
pyridine/H20 (60:12:40:48) . The plates were stained with ninhydrin and were exposed to X-ray film . In each case, the origin is indicated
(o) . None of the major [1251] peptides of the EGFR (A) corresponded to those of pyp55 (B) . The numbers indicate the locations of the
ninhydrin positive spots which were due to degraded fragments of trypsin and used to align the two maps .
al . (1987) have immunolocalized phosphotyrosine to the
cytosolic surface of endosomes in A431 cells after the ad-
ministration ofEGF . Even so, A431 cells have been reported
by Wiley et al . (1988) to be defective in internalization ofthe
EGFR . Hence, the studies of Carpentier et al . (1987) may
have underestimated the significance of phosphotyrosine
labeling in endosomes. A431 cells have been reported to
The Journal of Cell Biology, Volume 116, 1992
have ca . 2 x 106 receptors per cell (Haigler et al ., 1979 ;
Krupp et al ., 1982 ; Gamou et al ., 1984) . The much larger
hepatocyte has less than 105 receptors per cell (Lai et al.,
1989a) . It was perhaps not surprising therefore that ourown
attempts to visualizephosphotyrosine labeling in endosomes
by EM immunolabeling were unsuccessful (not shown) .
In vivo labeling ofthe EGFR was determined after immu-
328F
i
g
u
r
e
S
.
O
r
i
e
n
t
a
t
i
o
n
a
n
d
l
o
c
a
l
i
z
a
t
i
o
n
i
n
i
n
t
a
c
t
e
n
d
o
s
o
m
e
s
o
f
t
h
e
i
n
v
i
v
o
p
h
o
s
p
h
o
r
y
l
a
t
e
d
E
G
F
R
a
n
d
p
y
p
5
5
.
G
E
f
r
a
c
t
i
o
n
s
w
e
r
e
i
s
o
l
a
t
e
d
1
5
m
i
n
a
f
t
e
r
t
h
e
i
n
j
e
c
t
i
o
n
o
f
u
n
l
a
b
e
l
e
d
E
G
F
(
1
0
u
g
/
1
0
0
g
b
w
)
.
T
h
e
f
r
a
c
t
i
o
n
s
(
1
5
)
A
g
m
e
m
b
r
a
n
e
p
r
o
t
e
i
n
)
w
e
r
e
i
n
c
u
b
a
t
e
d
w
i
t
h
i
n
c
r
e
a
s
i
n
g
c
o
n
c
e
n
t
r
a
t
i
o
n
s
o
f
t
r
y
p
s
i
n
a
s
d
e
s
c
r
i
b
e
d
i
n
M
a
t
e
r
i
a
l
s
a
n
d
M
e
t
h
o
d
s
,
t
h
e
n
e
l
e
c
t
r
o
p
h
o
r
e
s
e
d
b
y
S
D
S
-
P
A
G
E
,
t
h
e
p
r
o
t
e
i
n
s
t
r
a
n
s
f
e
r
r
e
d
t
o
n
i
t
r
o
c
e
l
l
u
l
o
s
e
s
h
e
e
t
s
a
n
d
p
r
o
b
e
d
w
i
t
h
a
n
t
i
p
h
o
s
p
h
o
t
y
r
o
s
i
n
e
a
n
t
i
b
o
d
i
e
s
(
A
)
.
T
h
e
p
r
o
p
o
r
t
i
o
n
o
f
p
h
o
s
p
h
o
t
y
r
o
s
i
n
e
r
e
a
c
t
i
v
e
E
G
F
R
(
1
7
0
k
D
)
(
o
-
-
-
-
o
)
a
n
d
p
y
p
5
5
(
5
5
k
D
)
(
A
7
-
-
"
)
w
e
r
e
t
h
e
n
e
s
t
i
m
a
t
e
d
b
y
d
e
n
s
i
t
o
m
e
t
r
y
(
B
)
.
T
h
e
p
r
o
p
o
r
t
i
o
n
o
f
p
r
o
t
e
a
s
e
s
e
n
s
i
t
i
v
e
i
n
t
e
r
n
a
l
i
z
e
d
[
'
2
5
1
]
E
G
F
i
n
e
n
d
o
s
o
m
e
s
w
a
s
d
e
t
e
r
m
i
n
e
d
o
n
c
o
n
c
u
r
r
e
n
t
e
x
p
e
r
i
m
e
n
t
s
c
a
r
r
i
e
d
o
u
t
i
n
t
h
e
p
r
e
s
e
n
c
e
(
~
~
)
o
r
a
b
s
e
n
c
e
(
6
.
.
.
0
)
o
f
T
r
i
t
o
n
X
-
1
0
0
.noprecipitation with a mAb to the EGFR. Coprecipitating
with the EGFR was an associated phosphotyrosine-labeled
protein (pyp55) whose tyrosine phosphorylation was EGF
dependent. Pyp55 was also readily seen on immunoblotting
PM and endosome fractions with antiphosphotyrosine anti-
bodies. It was concluded that the protein was specifically as-
sociated with the EGFR in endosomes on the basis of its
coprecipitation as well as by its demonstrated association
during HPLC gel permeation chromatography ofsolubilized
endosomes. The molecular weight ofthe EGFR:pyp55 com-
plex was estimated by gel permeation chromatography to be
"440,000 which would be consistent with 2 tool of the
EGFR and 2 tool of pyp55. The phosphoprotein pyp55 was
found in association with the EGFR at initial timesofactiva-
tion at the cell surface, i.e., at 30 s as well as at peak times
of internalization in endosomes (5-15 min) . It was not possi-
ble to identify by Coomassie blue staining the amount of this
protein in immunoprecipitates since it was below the limit
of detection.
From their studies on the regulation of recycling of the Fc
receptor, Mellman et al. (1984) have proposed that condi-
tions favoring Fc receptor oligomerization would lead to
downregulation while conditions favoring receptor mono-
mer formation would lead to receptor recycling. The studies
of Honegger et al. (1987) and Felder et al. (1990) have sug-
gested that the tyrosine kinase activity ofthe EGFR in endo-
somes may be necessary for downregulation. Since our ex-
perimentalconditions (EGF dose of 10 ug/100 g bw) favored
downregulation (Lai et al., 19ß9a) we suggest that a possible
function of pyp55 is to regulate the oligomerization of the
EGFR in endosomes in a tyrosine phosphorylation depen-
dent manner thereby regulating receptor downregulation.
Current experiments aimed at purifying pyp55 and deter-
mining its primary structure by cDNA cloning could help
elucidate the significance of this EGFR-associated phos-
phoprotein.
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